Log In
BCIQ
Print this Print this
 

CEL-021

  Manage Alerts
Collapse Summary General Information
Company Celek Pharmaceuticals LLC
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationCystitis
Indication DetailsTreat interstitial cystitis (IC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today